glycopeptide

Phleomycin 是在链霉菌中发现的，引起 DNA 切割的抗癌糖肽抗生素之一。 它类似于博来霉素，它结合并插入 DNA 以破坏双螺旋的完整性。

A40926 (Dalbavancin Impurity) 是Dalbavancin 的前体，是一种糖肽抗生素。它抑制革兰氏阳性细菌，对淋病奈瑟氏球菌非常有效。

Sialylglycopeptide 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T64549，CAS号为 189035-43-6。

Dalbavancin (BI-397) HCl 是一种半合成的脂糖肽抗生素，对革兰氏阳性细菌有杀菌活性。Dalbavancin 抑制金黄色葡萄球菌和炭疽芽孢杆菌的 MIC90分别为 0.06 μg mL 和 0.25 μg mL。

Bleomycin sulfate 是一种糖肽类抗生素，具有抗肿瘤活性，是常用的DNA损伤剂和DNA合成抑制剂。它通过引起DNA链断裂而不影响RNA链，从而发挥作用。Bleomycin sulfate 常用于抗肿瘤研究，也被广泛应用于建立肺纤维化动物模型。

Bleomycin hydrochloride 是一种糖肽抗生素，一种 DNA 合成抑制剂。Bleomycin Sulfate 可以引起 DNA 链断裂而不引起 RNA 链断裂。Bleomycin Sulfate 具有抗肿瘤活性。

Vancomycin 是一种糖肽类抗生素，通过抑制易感细菌细胞壁合成的第二阶段发挥作用，同时还能改变细胞膜的渗透性并选择性地抑制核糖核酸的合成，从而具有抗菌活性。Vancomycin 常用于治疗对其他抗生素无效的严重感染，在实验研究中也常用于诱导肾损伤模型。

SNAP 398299 是一种甘丙肽受体 3 型 （Gal3）拮抗剂，具有抗焦虑和抗抑郁样作用，可用于研究情绪障碍。

Vancomycin hydrochloride (Vancomycin HCl) 是一种糖肽类抗生素,靶点是细菌细胞壁合成中的肽聚糖 (Peptidoglycan)。Vancomycin hydrochloride主要用于治疗严重的革兰阳性菌感染。

Teicoplanin (MDL-507) 是一种半合成的糖肽抗生素, 可用于由革兰氏阳性菌引起的严重感染的相关研究。

Dirithromycin (LY237216) 是一种红霉素衍生物，是一种具有口服活性的半合成大环内酯类抗生素。它用于治疗许多不同类型的细菌感染。

MAC-545496 是一种抗毒剂，可逆转耐甲氧西林的菌株中的 β-内酰胺耐药性。它是糖肽抗性相关蛋白 R 的纳摩尔抑制剂，对全长 GraR 蛋白具有很强的结合亲和力。

Mideplanin is a glycopeptide antibiotic.

Teicoplanin aglycone is an antibacterial glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including Enterococcus faecalis and methicillin-resistant Staphylococcus aureus.

Oritavancin diphosphate (LY333328 diphosphate) 是一种新型半合成的糖肽抗生素, 可研究革兰氏阳性菌感染。

Chloroorienticin A is an antibiotic in the class of glycopeptide.

Lipid II binder 5107930 is a lipid II binder which causes specific upregulation of the vancomycin-resistance associated gene vraX, which is implicated in the cell wall stress stimulon that confers glycopeptide resistance.

N-Demethylvancomycin is a glycopeptide antibiotic that has been found inNocardia orientalis.1It is active against several strains ofS. aureusandS. epidermidisin vitroandin vivo.2Formulations containing N-demethylvancomycin have been used in the treatment of bacterial infections. 1.Boeck, L.D., Mertz, F.P., Wolter, R.K., et al.N-demethylvancomycin, a novel antibiotic produced by a strain of Nocardia orientalis. Taxonomy and fermentationJ. Antibiot. (Tokyo)37(5)446-453(1984) 2.Hunt, A.H., Marconi, G.G., Elzey, T.K., et al.A51568A: N-demethylvancomycinJ. Antibiot. (Tokyo)37(8)917-919(1984)

Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.

Ristocetin A, a glycopeptide related to vancomycin, is an antibiotic produced by the microorganism Nocardia lurida[1]. Ristocetin A is currently in clinical use to treat bacterial infections [1]. Ristocetin A is an antibiotic which can be used to treat staphylococcal infections. The side effects of ristocetin A include thrombocytopenia and platelet agglutination. Ristocetin A has been used in two assays: the ristocetin cofactor assay and the ristocetin-induced platelet aggregation assay. These two assays could be used to diagnosis the von Willebrand disease and other bleeding disorders [2, 3]. The structural features of Ristocetin A are similar to vancomycin.

Parvodicin complex is a mixture of closely related lipophilic glycopeptides originally isolated from A. parvosata. The parvodicin complex has activity against Gram-positive bacteria (MICs = 0.8-12.5 μg ml) including methicillin-resistant strains of S. aureus (MRSA), S. hemolyticus, and E. faecalis (MICs = 0.1-25 μg ml). Glycopeptide antibiotics act by preventing cell wall synthesis by binding and sequestering a cell wall precursor with a D-alanine-containing peptide.

Sephadex G 50 is a gel filtration medium commonly utilized in gel permeation chromatography for effective fractionation of glycopeptide mixtures.

Vancomycin monohydrochloride is an amphoteric glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to peptidoglycan.

Bleomycin Free Base is a complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.